Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

Label Free Nanoscopy Using Infra Red

LANIR

Every year, Alzheimer's disease (AD) affects about 800,000 new patients in Europe and directly causes 50% of dependency of aged persons. Currently there is no test to diagnose this disease. There is a great need to improve outcomes for patients with lung cancer which causes between 15-28% of all cancer deaths in Europe. Chemical and structural...

Funding Programme
Start Date
End Date
Total Funding
€ 5 456 348
European Countries Involved

Large scale interactions in brain networks and their breakdown in brain diseases

BRAINSYNC

The long-term goal of this project is to understand how neuronal assemblies exchange information (functional or neuronal communication), and how variability in neuronal communication explains variability in behavioural performance, both in the intact and injured brain. Communication involves temporal interactions between neuronal assemblies either...

Funding Programme
Start Date
End Date
Total Funding
€ 3 933 811
European Countries Involved

Large-scale and wide-band brain dynamics mediating memory consolidation in the freely moving rat

Wide-Band Ephys

Dementia is a major healthcare challenge worldwide due to its high incidence and its strong impact on the life quality of patients and on society as a whole. Development of treatments for the mitigation of memory impairment in patients with dementia has proven very challenging, partly due to our limited understanding of the underlying mechanisms of...

Funding Programme
Start Date
End Date
Total Funding
€ 313 118
European Countries Involved

Longitudinal multi-omic profiling to provide a molecular map of human stroke

MAP-STROKE

Stroke is a leading and increasingly important cause of death and disability in the EU. Yet, we have only few effective treatments and an unsatisfactory understanding of human stroke pathophysiology. Current diagnostic algorithms fail to capture pathophysiological mechanisms in daily clinical practice, hindering the allocation of patients to...

Funding Programme
Start Date
End Date
Total Funding
€ 202 125
European Countries Involved

Loss of neurotrophic factors in neurodegenerative Dementias: Back to the crossroads of proteins

LODE

Neurodegenerative dementias are characterised by a continuous loss of neurons that are not replaced. Why neurons die in disease-affected brain regions is still a matter of discussion. This project explores a key common pathological mechanism across the three major neurodegenerative diseases leading to dementia: Alzheimer’s disease, Frontotemporal...

Funding Programme
Start Date
End Date
Total Funding
€ 1 020 000
European Countries Involved

Luminescent polymers for in vivo imaging of amyloid signatures

LUPAS

In this project we seek to develop new smart imaging molecular tools for combating neurodegenerative diseases such as Alzheimer’s disease and prion diseases. Emphasis is put on translational applied research for the development and validation of novel properly functionalized luminescent conjugated polymers (LCP) that via modern imaging technology...

Funding Programme
Start Date
End Date
Total Funding
€ 6 475 643
European Countries Involved

Machine learning methods for the reconstruction of dual tracer PET images

Dual Tracer PET

Positron Emission Tomography (PET) is a medical imaging technique that displays in vivo brain-wide metabolic processes. Prior to PET image acquisition, a tracer, labelled with a positron emitting isotope, is injected to the patient. This so-called radiotracer distributes over the body and accumulates in e.g. inflammatory tissue. To date, the...

Funding Programme
Start Date
End Date
Total Funding
€ 189 687
European Countries Involved

Magnetic DIagnostic Assay for neurodegenerative diseases

MADIA

MADIA aims at realizing a versatile and cheap diagnostic device based on magnetoresistive sensors, microfluidic device, ultra–small Magnetic Nanoparticles (MNPs) and advanced bio-chemical functionalization methods for the early and ultrasensitive. in vitro detection of biomarkers trustfully associated with 2 incurable neurodegenerative diseases...

Funding Programme
Start Date
End Date
Total Funding
€ 3 891 062
European Countries Involved

Managing active and healthy aging with use of caring service robots

MARIO

MARIO addresses the difficult challenges of loneliness, isolation and dementia in older persons through innovative and multi-faceted inventions delivered by service robots. The effects of these conditions are severe and life-limiting. They burden individuals and societal support systems. Human intervention is costly but the severity can be...

Funding Programme
Start Date
End Date
Total Funding
€ 3 994 857
European Countries Involved

Mechanism of protein kinases in biomolecular condensates

KinCond

Protein phosphorylation, mediated by kinases, plays a pivotal role in cellular regulation, with kinase dysregulation strongly associated with diseases like cancer, inflammation, and neurodegenerative disorders. Alzheimer's disease (AD) represents a significant global health challenge as the population ages at an accelerating pace. A key...

Funding Programme
Start Date
End Date
Total Funding
€ 173 847
European Countries Involved

Memory loss in Alzheimer disease: underlying mechanisms and therapeutic targets

MEMOSAD

MEMOSAD aims at defining the molecular mechanisms of Abeta- and Tau-induced synaptotoxicity and at developing disease-modifying therapeutics for the prevention of memory loss in Alzheimer disease (AD). Insoluble aggregates of the two proteins provide the pathological hallmarks of this incurable brain disorder. Early stage AD is characterized by a...

Funding Programme
Start Date
End Date
Total Funding
€ 4 023 080
European Countries Involved

METABOLIC BASIS OF NEURODEGENERATIVE DISEASE

BEYOND

Alzheimer disease (AD) is the most common form of age-related dementia affecting millions of patients worldwide. Disturbingly, disorders of lipid and glucose metabolism emerge as major risk factors for onset and progression of neurodegeneration in the human population. Thus, an increasing life expectance combined with an observable rise in...

Funding Programme
Start Date
End Date
Total Funding
€ 2 415 229
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).